Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 295,166 | 58,039 | 31,308 | 14,506 | 33,149 |
| Depreciation Amortization | 12,473 | 8,935 | 5,964 | 3,024 | 7,608 |
| Income taxes - deferred | -208,726 | N/A | N/A | N/A | N/A |
| Accounts receivable | -36,440 | -30,886 | -18,176 | -6,448 | -31,262 |
| Other Working Capital | -14,239 | -9,548 | -10,255 | -11,845 | -11,760 |
| Other Operating Activity | 65,607 | 54,858 | 33,802 | 16,692 | 55,464 |
| Operating Cash Flow | $113,841 | $81,398 | $42,643 | $15,929 | $53,199 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,026 | N/A | N/A | N/A | 9,368 |
| PPE Investments | -35,275 | -26,105 | -18,325 | -6,406 | -39,733 |
| Purchase Sale Intangibles | -27,740 | -27,740 | -27,740 | -12,500 | -8,624 |
| Other Investing Activity | -27,122 | -27,608 | -27,874 | -12,567 | -8,285 |
| Investing Cash Flow | $-81,423 | $-53,713 | $-46,199 | $-18,973 | $-38,650 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -44,301 | -24,221 | -145 | -71 | -273 |
| Common Stock Issued | 30,733 | 22,533 | 10,800 | 4,199 | 28,893 |
| Common Stock Repurchased | -1,416 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 714 | 0 | 0 | 0 | -312 |
| Financing Cash Flow | $-14,270 | $-1,688 | $10,655 | $4,128 | $28,308 |
| Exchange Rate Effect | 1,012 | 1,286 | 692 | -57 | -166 |
| Beginning Cash Position | 138,012 | 138,012 | 138,012 | 138,012 | 95,321 |
| End Cash Position | 157,172 | 165,295 | 145,803 | 139,039 | 138,012 |
| Net Cash Flow | $19,160 | $27,283 | $7,791 | $1,027 | $42,691 |
| Free Cash Flow | |||||
| Operating Cash Flow | 113,841 | 81,398 | 42,643 | 15,929 | 53,199 |
| Capital Expenditure | -35,275 | -26,105 | -18,325 | -6,406 | -39,733 |
| Free Cash Flow | 78,566 | 55,293 | 24,318 | 9,523 | 13,466 |